INVIGO FLEX Pain Relief Gel

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: INVIGO FLEX Pain Relief Gel
Generic name: MENTHOL
Manufacturer: WYNNPHARM INC.
Product type: HUMAN OTC DRUG
SPL set ID: 909e1d8c-c517-4d6a-8682-894f042c00f8
SPL ID: 09d70e71-d1be-2749-e063-6294a90abd05
Version: 2
Effective date: 2023-11-10
Source export date: 2026-09-28
Source partition: 1
Source file: https://download.open.fda.gov/drug/label/drug-label-0001-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/9c7783846d422acb0c9e59457606951c785a7d28cc631c8cc4839d0dc7c55f39/drug-label-0001-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:14:06

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		INVIGO FLEX Pain Relief Gel	openfda.brand_name
generic name		MENTHOL	openfda.generic_name
manufacturer name		WYNNPHARM INC.	openfda.manufacturer_name
ndc	package	35324-276-00	openfda.package_ndc
ndc	product	35324-276	openfda.product_ndc
ndc11	package	35324027600	derived:openfda.package_ndc
rxcui		259150	openfda.rxcui
spl id		09d70e71-d1be-2749-e063-6294a90abd05	id
spl set id		909e1d8c-c517-4d6a-8682-894f042c00f8	set_id
unii		L7T10EIP3A	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings: For external use only Do not use • on damaged or broken skin. When using this product • Avoid contact with the eyes. • Do not bandage tightly. Stop use and ask a doctor • rash or irritation develops and lasts. • condition worsens, or if symptoms persist for more than 7 days or clears up and occur again within a few days. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away. If pregnant or breast-feeding, ask a health professional before use.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.